Biomarkers Companies in BioPortfolio's Corporate DatabaseTwitter RSS

13:45 EST 19th February 2017 | BioPortfolio

Biomarkers company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Biomarkers companies that have been added to our BioPortfolio's life-science corporate directory.

Search For More Biomarkers Companies

If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Biomarkers Companies.

More Information about Biomarkers on BioPortfolio

We have published hundreds of Biomarkers news stories on BioPortfolio along with dozens of Biomarkers Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Biomarkers for you to read.

Showing "biomarkers biomarker" Companies 1 to 25 of 214

Thursday 9th February 2017


NeuroPointDX is the diagnostics division of Stemina Biomarker Discovery. Stemina is a biotechnology company based in Madison, WI and Cambridge, MA that has developed a robust and reproducible proprietary platform for identifying changes in metabolism (“biomarkers”) utilizing highly sensitive analytical equipment and its proprietary platform technology. ...

Saturday 4th February 2017

Quanterix Corporation Quanterix

Quanterix is a company that’s digitizing biomarker analysis to advance the science of precision health. The company’s digital health solution, Simoa, is changing the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. In doing so, Quanterix enables much earlier disease ...

Tuesday 8th March 2016

Abreos Biosciences

Abreos Biosciences is focused on ligand binding assays for biologic and biosimilar drug development, activity validation, authentication, and precision dosing, as well as massively multiplexed biomarker assays. Abreos has already developed reagents for the detection of several drugs currently available on the market such as rituximab, obinutuzumab, trastuz...

Thursday 3rd March 2016

The FlowMetric Family of Companies

The FlowMetric Family of Companies consist of FlowMetric, Inc. and two additional affiliate companies, FlowMetric Europe, S.p.A. and FlowMetric Diagnostics, Inc. FlowMetric, Inc. and FlowMetric Europe, S.p.A., founded in 2010 and 2013 respectively, are niche contract research organizations (CROs), focused on providing polychromatic flow cytometry and cell ...

Wednesday 2nd March 2016

Xcell Biosciences, Inc.

Xcell Biosciences, Inc., is developing revolutionary products and workflows for life science and translational research that reproduce physiologically relevant conditions to enable more meaningful, biologically relevant experiments. The company’s tools empower scientists to obtain accurate and actionable results in important fields such as cancer rese...

Tuesday 23rd February 2016

Ignyta Inc.

At Ignyta, we fight cancer – a formidable opponent that manifests as thousands of different molecularly defined diseases and takes away millions of lives globally, every year. In this fight, our big hairy audacious goal (BHAG) is not just to shrink tumors but to eradicate residual disease – the source of cancer relapse and recurrence – in pr...

Thursday 18th February 2016

Pliant Therapeutics

Pliant Therapeutics is an early-stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. By leveraging its powerful product engine, Pliant’s mission is to prevent or even reverse fibrosis, restoring organ function. The company also aims to build a ...

Thursday 21st January 2016

Biodesy, Inc.

Biodesy is developing the first products and systems to rapidly and inexpensively measure both protein structure and function in real time, with applications including drug discovery, structural biology, and clinical biomarkers. Biodesy has developed a unique and highly sensitive technology for detecting conformational change in proteins and other biologic...

Friday 8th January 2016

GNS Healthcare and Global Genomics Group

G3 is a global leader in pan-omics and investigates biological networks that lead to the development of disease to identify novel biomarkers and therapeutic targets. G3 combines precision phenotyping with pan-omics (genomics, epigenomics, transcriptomics, proteomics, metabolomics, lipidomics and lipoprotein proteomics) and systems-biology driven bioinforma...

Thursday 3rd December 2015


Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The company designs and analyzes sets of biomarkers known to be linked to a part...

Tuesday 10th November 2015

Neurogenetic Pharmaceuticals, Inc.

Neurogenetic Pharmaceuticals, Inc. (NGP) is a biopharmaceutical discovery and development company founded in 2009 which is focused on developing innovative drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimer’s disease. Based in San Diego, Calif., the company’s next objective is to obtain an Investigational New...

Thursday 22nd October 2015

Minomic International Ltd

Minomic International Ltd is an Australian immuno-oncology company specialising in therapeutics and diagnostics for prostate cancer and other cancers. Minomic has developed the in vitro diagnostic test called MiCheck® for the early detection of prostate cancer. Minomic is preparing to globally launch its first product, a novel prostate cancer blood test...

Monday 19th October 2015

Luc Therapeutics Inc.

Luc (pronounced ‘Luke’) Therapeutics – formerly Mnemosyne Pharmaceuticals – is a private, Cambridge, MA-based biotechnology company dedicated to discovering and developing medicines for patients living with serious psychiatric diseases. The company combines deep expertise in the pharmacology of NMDA receptors – critical modulators of ...

Monday 5th October 2015

Immunovia AB

Immunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, e...

Wednesday 23rd September 2015

Stemina Biomarker Discovery Inc.

Stemina Biomarker Discovery was founded in 2007 and is located in Madison, Wisconsin. Stemina is a biomarker discovery company focused on diagnosis and individualized treatment of neurological disorders including autism spectrum disorders. Stemina uses its proprietary metabolomics platform to identify changes in metabolism that can be biomarkers more effec...

Tuesday 11th August 2015


Celmatix, Inc. is a New York City-based biotechnology company targeting the reproductive medicine sector. The company aims to provide molecular diagnostic products and services to patients based on proprietary genetic biomarkers for infertility. Currently, infertility is diagnosed by a financially and emotionally costly process of trial and error. Celmatix aims to provide products and services to ...

Tuesday 16th June 2015

FlowMetric Diagnostics Inc.

FlowMetric Diagnostics, an affiliate of FlowMetric Inc., based in Doylestown, PA and founded in December 2013, utilizes a flow cytometry-based platform to analyze cell-mediated immune responses. The company’s proprietary assays require only small volumes of capillary blood, eliminating the need for venous blood draw. The technology can be readily adap...

Monday 1st June 2015

BioMarker Strategies, LLC

BioMarker Strategies has developed SnapPath®, the only cancer diagnostics system that automates and standardizes functional ex vivo profiling of live solid tumor cells from fresh biopsies or other fresh, unfixed samples such as xenografts or tumorgrafts. SnapPath® can help guide cancer drug development and treatment selection. The Company’s Path...

Thursday 30th April 2015

Prolias Technologies, Inc.

Prolias Technologies is an emerging molecular diagnostics company focusing on predictive and prognostic genetic cytology. Our novel molecular tests provide a definitive pathological diagnosis that allows for more accurate utility of surgical procedures. We are committed to revolutionizing patient care through discovery and commercialization of molecular te...

Wednesday 15th April 2015

Avant Diagnostics, Inc.

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in large panel biomarker screening. Our first test, OvaDx®, developed in conjunction with Arrayit Corporation (OTCQB: ARYC), detects for pre-symptomatic ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system i...

Thursday 9th April 2015

DermTech, Inc.

Headquartered in La Jolla, California, DermTech International ( is developing its proprietary EGIR(TM) (Epidermal Genetic Information Retrieval) technology for genomic-based, non-invasive disease detection, improved pharmaceutical R&D and personalized medicine to help direct appropriate treatment. The company's first product candidate in development is a non-invasive test to dete...

Thursday 2nd April 2015

Amplion Inc.

Amplion publishes BiomarkerBase™ (, the most complete database of biomarkers in clinical use and development. BiomarkerBase™ includes every biomarker used in and FDA-approved test or drug label, and thousands of biomarkers being used and developed in clinical trials. Many of the world’s leading diagnostics and bi...

Friday 20th February 2015

Cerecor Inc.

Driven by an innovative team of industry experts and leading scientists, Cerecor aspires to develop neuroscience drugs that will make a difference. We are committed to improving the lives of patients by addressing underserved segments of common diseases. We are focused exclusively on developing products that have human proof-of-concept in either the target...

Wednesday 4th February 2015

sphingotec LLC

Headquartered in Hennigsdorf, Germany, biotechnology company sphingotec GmbH was founded in 2002. sphingotec GmbH aims to develop diagnostic methods for prediction, prevention, intervention strategies and early treatment of diseases in the fields of cancer, cardiovascular diseases and kidney function. Using biomarkers to indicate susceptibility for a speci...

Monday 12th January 2015

Neviah Genomics

Neviah Genomics was jointly established in 2012 by Merck Serono, the biopharmaceutical business of Merck, and Compugen Ltd. The company operates out of the MS Ventures’ Israel Bioincubator and is focused on identifying and developing novel biomarkers for the prediction of drug-induced toxicity. MS Ventures’ Israel BioIncubator provided the initia...

More From BioPortfolio on "Biomarkers Companies in BioPortfolio's Corporate Database"

Quick Search

Corporate Database Quicklinks